Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP-Reference-Cited by-同舟云学术

Group II metabotropic glutamate receptors are a common target of N-anisoyl-GABA and 1S,3R-ACPD in enhancing ACh release in the prefrontal cortex of freely moving SHRSP

Published:2000-04 Issue:5 Volume:39 Page:866-872
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Shirane Masatoshi,Nakamura Kazuo

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference46 articles.

1. Neurotrophins and depression;Altar;Trends in Pharmacological Science,1999

2. Cell body infusions of brain-derived neurotrophic factor increase forebrain dopamine release and serotonin metabolism determined with in vivo microdialysis;Altar;Advances in Pharmacology,1998

3. Glutamate receptor agonists enhance the expression of BDNF mRNA in cultured cerebellar granule cells;Bessho;Brain Research and Molecular Brain Research,1993

4. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia;Bond;NeuroReport,1998

5. Seizures and neuronal damages induced in the rat by activation of group I metabotropic glutamate receptors with their selective agonist 3,5-dihydroxyphenylglycine;Camon;Journal of Neuroscience Research,1998

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-16

2. Clinical Efficacy of Aniracetam, Either as Monotherapy or Combined with Cholinesterase Inhibitors, in Patients with Cognitive Impairment: A Comparative Open Study*;CNS Neuroscience & Therapeutics;2011-02-26

3. Modern approaches to the design of memory and cognitive function stimulants based on AMPA receptor ligands;Russian Chemical Reviews;2009-05-31

4. Pharmacology of Ampakine Modulators: From AMPA Receptors to Synapses and Behavior;Current Drug Targets;2007-05-01

5. Aniracetam: Its Novel Therapeutic Potential in Cerebral Dysfunctional Disorders Based on Recent Pharmacological Discoveries;CNS Drug Reviews;2006-06-07